More intelligence articles

Addressing the payer-regulator evidence gap in early-stage cancer

By Jason Ward

Health trust in a COVID-19 world – a unique opportunity for pharma

The COVID-19 pandemic is a pivotal moment and, for some within the healthcare sector, this could be a once-in-a-generation opportunity to change the narrative

Facing up to virtual reality

As COVID-19 continues to have a cataclysmic impact on face-to-face events, 70% of event planners have moved some of their face-to-face meetings to virtual platforms and many believe that we’ll

A snapshot of… Enterprise Therapeutics

AI and genomics: a revolution in drug discovery and development

Working together against COVID-19

Analysing social media conversations to see what HCPs are saying online about the global pandemic

The big issue

Whether you want to lead or follow, you need to understand the elephant in the C-suite

COVID-19: the race to find a vaccine

How biopharma is working to bring an end to the pandemic

Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy

Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval

After the watershed: the dos and don’ts of digital KPIs in a post-pandemic world

Chris Ross looks at how COVID-19 is forcing businesses to reconfigure their commercial strategies around digital channels

Emerging use cases of blockchain in healthcare and the life sciences

By Charles Wright

Managing virtual teams

With coronavirus leading to mass home working, how do we get the best from our now virtual teams while supporting their health and well-being

Risks, reforms and rewards: the evolving Russian healthcare market

While reforms introduced in the past two decades have brought stability and sought to address some of the structure issues, problems remain

Biopharma and orphan drugs

Rare disease drug approvals are improving, thanks to regulatory support

GSK forges ahead with its dynamic COPD and asthma portfolio

A landmark year of discovery and development in COPD brings hope to millions of patients